Advertisement
Advertisement
U.S. markets open in 2 hours 41 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Aurinia Pharmaceuticals Inc. (AUPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.01-0.36 (-2.91%)
At close: 04:00PM EDT
12.24 +0.23 (+1.92%)
After hours: 07:30PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close12.37
Open12.45
Bid0.00 x 1800
Ask0.00 x 2200
Day's Range11.90 - 12.57
52 Week Range8.86 - 33.97
Volume2,099,693
Avg. Volume2,533,413
Market Cap1.702B
Beta (5Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)-1.26
Earnings DateAug 03, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est23.81
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AUPH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Aurinia Pharmaceuticals Inc
    Daily – Vickers Top Insider Picks for 08/11/2021The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    11 months agoArgus Research
View more
  • Zacks

    Aurinia (AUPH) Moves 13.3% Higher: Will This Strength Last?

    Aurinia (AUPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

  • Motley Fool

    Why Aurinia Pharmaceuticals Stock Perked Up Today

    Shares of the commercial-stage biopharma Aurinia Pharmaceuticals (NASDAQ: AUPH) rose by as much as 13.7% during Friday's trading session. This time around, Japanese drug manufacturer Otsuka Holdings is rumored to be considering a bid, according to a report posted on the subscription-based Betaville website and subsequently circulated on Twitter. Aurinia, for its part, has not commented on this takeover speculation.

  • Business Wire

    Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    VICTORIA, British Columbia, June 06, 2022--Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Advertisement
Advertisement